Fast-Growing German Biotech Affimed Chooses Generis CARA™ Life Science Platform for Clinical R&D
London, UK -March 2nd, 2022 – Generis, the world’s leading provider of cloud-based content and regulatory information management solutions, today announced that the ambitious German